Medpace Holdings, Inc.
MEDPCIK 0001668397
Revenue (TTM)
$2.53B
+20.0% YoY
Q1 Apr 2026
Net Income (TTM)
$439.86M
+11.6% YoY
Q1 Apr 2026
EPS Diluted (TTM)
$14.91
+21.0% YoY
Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
20.7%
Q1 Apr 2026
Net Margin
17.4%
Q1 Apr 2026
Free Cash Flow (TTM)
$478.56M
Q1 Apr 2026
Cash
$652.68M
Q1 Apr 2026
Total Debt
$0
Q1 Apr 2026
Shares Outstanding
28.56M sh
Q1 Apr 2026